Home / Health / Advanced Cancers Drive Indian Patients Overseas for Treatment
Advanced Cancers Drive Indian Patients Overseas for Treatment
4 Sep
Summary
- Singapore center reports a 20% increase in Indian cancer patients in 2025.
- Many Indian patients arrive with advanced disease, limiting curative options.
- Molecular profiling transforms treatment for stage four cancers.
Singapore's Parkway Cancer Centre reported a nearly 20% rise in Indian patient numbers in 2025. A concerning trend reveals that 60-70% of these patients have advanced or treatment-resistant cancers, arriving when fewer curative options remain.
Many patients travel abroad after exhausting treatments in India, seeking a different medical perspective. The center emphasizes the critical importance of accurate diagnosis, including molecular profiling, for effective cancer care. Advanced stage cancers are increasingly manageable due to molecular profiling, offering significant survival benefits for specific genetic mutations.
Parkway Cancer Centre aims to complete investigations within 48 hours for overseas patients. While global cancer cases rise due to aging populations and better detection, India faces infrastructure challenges. Prevention, early detection, and improved doctor-patient communication are vital for better outcomes.
